These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2715143)

  • 41. Is carbamazepine a potential drug of abuse?
    Sullivan G; Davis S
    J Psychopharmacol; 1997; 11(1):93-4. PubMed ID: 9097899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The syndrome of anticholinergic intoxication.
    Feldman MD
    Am Fam Physician; 1986 Nov; 34(5):113-6. PubMed ID: 3776789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levodopa dependence and abuse in Parkinson's disease.
    Spigset O; von Schéele C
    Pharmacotherapy; 1997; 17(5):1027-30. PubMed ID: 9324193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abuse liability of buprenorphine--a study among experienced drug users.
    Bedi NS; Ray R; Jain R; Dhar NK
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):95-100. PubMed ID: 9513799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A
    Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
    [No Abstract]   [Full Text] [Related]  

  • 46. Use and abuse of anticholinergic drugs in psychiatry.
    Gelenberg AJ
    Hillside J Clin Psychiatry; 1984; 6(2):148-55. PubMed ID: 6396187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimation of atropine and some anticholinergics chemically related to atropine, on the isolated rat jejunum.
    Sund RB
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):84. PubMed ID: 5314451
    [No Abstract]   [Full Text] [Related]  

  • 48. Abuse liability of diazepam through different routes.
    Singh RK; Jain R; Ray R; Gupta YK
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):181-90. PubMed ID: 11480224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced sexual dysfunction in older men.
    Van Arsdalen KN; Wein AJ
    Geriatrics; 1984 Oct; 39(10):63-7, 70. PubMed ID: 6541174
    [No Abstract]   [Full Text] [Related]  

  • 50. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antispasmodic anticholinergics].
    Taurand S
    Soins; 1990 May; (536):I-II. PubMed ID: 2377913
    [No Abstract]   [Full Text] [Related]  

  • 52. [The anticholinergics. Pharmacologic evaluation in man].
    Buffa E; Ezechieli S; Frigerio G; Lodola E; Sacchetti G
    Boll Chim Farm; 1966 Feb; 105(2):107-11. PubMed ID: 5940320
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anticholinergics as bronchodilators. An action profile].
    Ulmer WT; Höltmann B; Schmidt EW; Schött D
    Arzneimittelforschung; 1987 Oct; 37(10):1185-92. PubMed ID: 2963644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of amitriptyline abuse.
    Delisle JD
    Am J Psychiatry; 1990 Oct; 147(10):1377-8. PubMed ID: 2400006
    [No Abstract]   [Full Text] [Related]  

  • 55. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans.
    Hameedi FA; Rosen MI; McCance-Katz EF; McMahon TJ; Price LH; Jatlow PI; Woods SW; Kosten TR
    Biol Psychiatry; 1995 Apr; 37(8):560-3. PubMed ID: 7619981
    [No Abstract]   [Full Text] [Related]  

  • 56. Brain arousal regulation as response predictor for antidepressant therapy in major depression.
    Schmidt FM; Sander C; Dietz ME; Nowak C; Schröder T; Mergl R; Schönknecht P; Himmerich H; Hegerl U
    Sci Rep; 2017 Mar; 7():45187. PubMed ID: 28345662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Euphorigenic properties of anticholinergics.
    Knable MB
    J Clin Psychiatry; 1989 May; 50(5):186. PubMed ID: 2715143
    [No Abstract]   [Full Text] [Related]  

  • 58. Trihexyphenidyl abuse for euphorigenic effect.
    Goggin DA; Solomon GF
    Am J Psychiatry; 1979 Apr; 136(4A):459-60. PubMed ID: 426119
    [No Abstract]   [Full Text] [Related]  

  • 59. [The suppressed medication with far-reaching consequences].
    Dieleman BP; van den Broek WW; van de Wetering BJ
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):335-6. PubMed ID: 1538803
    [No Abstract]   [Full Text] [Related]  

  • 60. Phenylpropanolamine: toward resolution of a controversy.
    Winick C
    J Clin Psychopharmacol; 1991 Apr; 11(2):79-81; discussion 82. PubMed ID: 2056145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.